Keros Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
KROS on Nasdaq
Location
1050 Waltham Street, Suite 302, Lexington, Massachusetts

Insiders trading volume in the past year

Keros Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Tomer Kariv Director, More than 10% owner $55.5M Jun 6, 2023
Pontifax Management 4 G.P. (2015) Ltd. More than 10% owner $55.5M Nov 29, 2022
Ran Nussbaum Director, More than 10% owner $55.5M Jun 6, 2023
Jasbir Seehra CHIEF EXECUTIVE OFFICER, Director $11.5M Feb 23, 2024
Jennifer Lachey Chief Scientific Officer $4.31M Jul 15, 2022
Julius Knowles Director $53.9K Jun 6, 2023
Christopher Rovaldi Chief Operating Officer Feb 13, 2024
Simon Cooper Chief Medical Officer Feb 13, 2024
Carl L. Gordon Director Jun 6, 2023
Mary Ann Gray Director Jun 6, 2023
Nima Farzan Director Jun 6, 2023
Claudia Ordonez Chief Medical Officer Jun 11, 2021
Keith Regnante Chief Financial Officer -$3.68M Feb 13, 2024
Alpna Seth Director Jun 6, 2023

Recent Insider Transactions by Companies or Individuals for Keros Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership